FDA
approval
· 2018-02-01
FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Micardis (telmisartan) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval pertains to changes authoriz…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MICARDIS (TELMISARTAN)